Endocrine Testing Market Is Expected To Reach USD 13.0 Billion By 2024: By Grand View Research, Inc.

The global endocrine testing market is expected to reach USD 13.0 billion by 2024, according to a new report by Grand View Research, Inc.The growing geriatric population and persisting cases of illnesses, such as diabetes and obesity, are estimated to drive the market.

The target population for this industry is geriatric patients as they are highly prone to various chronic disorders. They have decreased immunity, are prone to age-related deformities, and are at a higher risk of developing complications. As per the WHO statistics on geriatric population, there would be a two-fold rise in the geriatric population; for example, in the U.S. by 2050, geriatric patient count of age 65 and above would be 83.7 million as compared to 43.1 million in 2012.

Sedentary lifestyles of people with unhealthy food habits, and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is anticipated to contribute to industry growth substantially.

Technological advancements in terms of accuracy and affordability resulted in an increased usage of these tests. For instance, the influx of test kits, for home-based testing has fostered the demand for these techniques, helping the market to grow.

North America endocrine testing market share, by technology, 2013 - 2024 (USD Million)




Browse full research report on Endocrine Testing Market

Further key findings from the study suggest:

  • The thyroid stimulating hormone test segment held a lucrative share of over 25.0% in 2015 among test type segments.The increasing cases of hyperthyroidism and hypothyroidism are anticipated to contribute to the growth.
  • In the technology segment, the immunoassay technology segment shared the highest market share owing to the increased analysis of hormonal levels using Radioimmunoassay(RIA) and enzyme-linked assays
  • The commercial laboratories in the end-use segment exhibited remunerative growth in 2015 and this can be attributed to the presence of sophisticated work environment, which yields faster and accurate diagnosis. Moreover, the dominance of private healthcare sector in developing nations contributed to the growth. For instance, in India, approximately 87.0% healthcare is privately financed. In 20 developing countries, their 40-70% GDP is utilized for out-of-pocket expenses in healthcare.
  • On the other hand, the home-based test segment is anticipated to witness a lucrative growth over the forecast period. Convenience and affordability of home-based testing are anticipated to contribute to the growth. Additionally, as per the U.S. Bureau of Labor Statistics, since easy-to-use diagnostic kits have been introduced the rank of home-based tests is expected to increase, which in turn isfurther expected to support the lucrative growth rate.
  • North America dominated the overall market with a revenue share of over 38.0% in 2015, owing to the presence of well-developed hospitals, reimbursement network, government funding, and the increasing health awareness among people
  • However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 9.0% over the forecast period.Economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to assist the growth.
  • Key players of the industry include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMérieuxSA, Bio-Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Technology.
  • Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancements that are helping them sustain themselves in the competition.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Image
The global  hyaluronic acid market   is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.  The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid - based dermal fillers are attracting this population base.  The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that b...
Read more

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.

Image
The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysi...
Read more